Eric Coldwell
Stock Analyst at Baird
(0.83)
# 3,860
Out of 4,960 analysts
201
Total ratings
50%
Success rate
-10.41%
Average return
Main Sectors:
Stocks Rated by Eric Coldwell
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PINC Premier | Maintains: Neutral | $22 → $27 | $25.14 | +7.40% | 9 | Aug 20, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $197 → $203 | $148.10 | +37.07% | 13 | Aug 13, 2025 | |
| OMI Owens & Minor | Maintains: Outperform | $10 → $7 | $5.05 | +38.61% | 19 | Aug 12, 2025 | |
| FTRE Fortrea Holdings | Upgrades: Outperform | $7 → $9 | $8.34 | +7.98% | 8 | Aug 4, 2025 | |
| LH Labcorp Holdings | Maintains: Outperform | $290 → $302 | $278.18 | +8.56% | 14 | Jul 25, 2025 | |
| ICLR ICON Public Limited Company | Upgrades: Outperform | $150 → $224 | $175.83 | +27.40% | 21 | Jul 24, 2025 | |
| MEDP Medpace Holdings | Maintains: Neutral | $313 → $490 | $463.64 | +5.69% | 19 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Neutral | $159 → $196 | $191.15 | +2.54% | 18 | Jul 23, 2025 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $118 → $140 | $161.84 | -13.49% | 14 | May 8, 2025 | |
| DGX Quest Diagnostics | Maintains: Outperform | $191 → $194 | $180.23 | +7.64% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $14 → $16 | $9.61 | +66.49% | 10 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $531 → $688 | $689.45 | -0.21% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $51 | $12.07 | +322.54% | 16 | Apr 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $35 → $45 | $62.21 | -27.66% | 2 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $62 → $66 | $71.30 | -7.43% | 7 | May 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $67 → $46 | $1.65 | +2,687.88% | 4 | Nov 10, 2017 |
Premier
Aug 20, 2025
Maintains: Neutral
Price Target: $22 → $27
Current: $25.14
Upside: +7.40%
Cardinal Health
Aug 13, 2025
Maintains: Outperform
Price Target: $197 → $203
Current: $148.10
Upside: +37.07%
Owens & Minor
Aug 12, 2025
Maintains: Outperform
Price Target: $10 → $7
Current: $5.05
Upside: +38.61%
Fortrea Holdings
Aug 4, 2025
Upgrades: Outperform
Price Target: $7 → $9
Current: $8.34
Upside: +7.98%
Labcorp Holdings
Jul 25, 2025
Maintains: Outperform
Price Target: $290 → $302
Current: $278.18
Upside: +8.56%
ICON Public Limited Company
Jul 24, 2025
Upgrades: Outperform
Price Target: $150 → $224
Current: $175.83
Upside: +27.40%
Medpace Holdings
Jul 23, 2025
Maintains: Neutral
Price Target: $313 → $490
Current: $463.64
Upside: +5.69%
IQVIA Holdings
Jul 23, 2025
Maintains: Neutral
Price Target: $159 → $196
Current: $191.15
Upside: +2.54%
Charles River Laboratories International
May 8, 2025
Maintains: Neutral
Price Target: $118 → $140
Current: $161.84
Upside: -13.49%
Quest Diagnostics
Apr 23, 2025
Maintains: Outperform
Price Target: $191 → $194
Current: $180.23
Upside: +7.64%
Feb 27, 2025
Maintains: Outperform
Price Target: $14 → $16
Current: $9.61
Upside: +66.49%
Nov 7, 2024
Upgrades: Outperform
Price Target: $531 → $688
Current: $689.45
Upside: -0.21%
Apr 1, 2022
Downgrades: Neutral
Price Target: $51
Current: $12.07
Upside: +322.54%
Jun 26, 2020
Maintains: Neutral
Price Target: $35 → $45
Current: $62.21
Upside: -27.66%
May 7, 2020
Maintains: Neutral
Price Target: $62 → $66
Current: $71.30
Upside: -7.43%
Nov 10, 2017
Maintains: Outperform
Price Target: $67 → $46
Current: $1.65
Upside: +2,687.88%